Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction
- PMID: 18443364
- PMCID: PMC2443608
- DOI: 10.1369/jhc.2008.950816
Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction
Abstract
We examined the endothelial gap junctions in diabetic hyperlipidemic mice. Male apolipoprotein E (apoE)-deficient mice were made diabetic by streptozotocin. Three weeks later, the animals were treated with simvastatin for 2 weeks. The expression of aortic gap junctions in the non-diabetic (n=10), untreated diabetic (n=10), and simvastatin-treated diabetic animals (n=6) was analyzed. There was a >4-fold increase in serum cholesterol level and >50% increase in plaque areas in the diabetic mice, regardless of simvastatin treatment. Western blotting of aortae showed reduced expression of connexin37 (Cx37) and Cx40 in the diabetic mice, which were further decreased in the simvastatin-treated diabetic mice. Immunoconfocal microscopy showed that endothelial gap junctions made of Cx37 and Cx40 were both reduced in the untreated diabetic mice compared with the non-diabetic mice (decrease: Cx37, 41%; Cx40, 42%; both p<0.01). The reduction was greater in the simvastatin-treated mice (decrease in treated diabetic vs non-diabetic: Cx37, 61%; Cx40, 79%; both p<0.01; decrease in treated diabetic vs untreated diabetic: Cx37, 34%; Cx40, 63%; both p<0.01). Cx37 and Cx40 were decreased in the endothelium of plaque surface. Cx43 appeared in the medial layer and inner layer of the intima. All three connexins were rarely expressed in monocytes/macrophages inside the plaques. In conclusion, in apoE-deficient mice, streptozotocin-induced diabetes is associated with downregulation of endothelial Cx37 and Cx40 gap junctions. Short-term treatment with simvastatin exacerbates the downregulation.
Figures






Similar articles
-
Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment.Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1391-7. doi: 10.1161/01.ATV.0000083508.21989.15. Epub 2003 Jun 26. Arterioscler Thromb Vasc Biol. 2003. PMID: 12829525
-
Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40.J Cell Sci. 2003 Jun 1;116(Pt 11):2223-36. doi: 10.1242/jcs.00429. Epub 2003 Apr 15. J Cell Sci. 2003. PMID: 12697838
-
Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40.J Vasc Res. 2002 Mar-Apr;39(2):160-72. doi: 10.1159/000057764. J Vasc Res. 2002. PMID: 12011587
-
Gap junctions and the connexin protein family.Cardiovasc Res. 2004 May 1;62(2):228-32. doi: 10.1016/j.cardiores.2003.11.013. Cardiovasc Res. 2004. PMID: 15094343 Review.
-
Vascular gap junctions and implications for hypertension.Clin Exp Pharmacol Physiol. 2004 Oct;31(10):659-67. doi: 10.1111/j.1440-1681.2004.04071.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15554905 Review.
Cited by
-
Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.Clin Exp Nephrol. 2014 Aug;18(4):584-92. doi: 10.1007/s10157-013-0922-5. Epub 2013 Dec 20. Clin Exp Nephrol. 2014. PMID: 24357461 Free PMC article. Review.
-
Beneficial effect of simvastatin on human umbilical vein endothelial cells gap junctions induced by TNF-α.Anim Cells Syst (Seoul). 2022 Jan 16;26(1):10-18. doi: 10.1080/19768354.2021.2023037. eCollection 2022. Anim Cells Syst (Seoul). 2022. PMID: 35308127 Free PMC article.
-
Biological and biophysical properties of vascular connexin channels.Int Rev Cell Mol Biol. 2009;278:69-118. doi: 10.1016/S1937-6448(09)78002-5. Int Rev Cell Mol Biol. 2009. PMID: 19815177 Free PMC article. Review.
-
Endothelial dysfunction in diabetes: multiple targets for treatment.Pflugers Arch. 2010 May;459(6):977-94. doi: 10.1007/s00424-010-0807-3. Epub 2010 Mar 18. Pflugers Arch. 2010. PMID: 20238124 Review.
-
Endothelial Connexins in Developmental and Pathological Angiogenesis.Cold Spring Harb Perspect Med. 2022 May 27;12(5):a041158. doi: 10.1101/cshperspect.a041158. Cold Spring Harb Perspect Med. 2022. PMID: 35074793 Free PMC article. Review.
References
-
- Balk EM, Karas RH, Jordan HS, Kupelnick B, Chew P, Lau J (2004) Effects of statins on vascular structure and function: a systematic review. Am J Med 117:775–790 - PubMed
-
- Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME, Jandeleit-Dahm KA (2004) Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109:1536–1542 - PubMed
-
- Chadjichristos CE, Derouette JP, Kwak BR (2006) Connexins in atherosclerosis. Adv Cardiol 42:255–267 - PubMed
-
- Dilaveris P, Giannopoulos G, Riga M, Synetos A, Stefanadis C (2007) Beneficial effects of statins on endothelial dysfunction and vascular stiffness. Curr Vasc Pharmacol 5:227–237 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous